⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 2, 2022Liver InternationalOpen Access

Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory

Chenxi Li Wenqiang He

View Full Paper

Ask AI

Bookmark

Share

Abstract

While the ASR of primary liver cancer mortality was comparable across the three data sources, most similar estimates were found between WHO and GCO. The opposite trends found from 10 countries between WHO and GBD raised concerns of true patterns in these countries.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2022) studied this question.

synapsesocial.com/papers/69d96a3b8988aeabbe685467 https://doi.org/10.1111/liv.15357

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 108,286 citations
2The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017Original Research · 2021 · 20 citations
3Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019Original Research · 2020 · 19,310 citations
4What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease studyOriginal Research · 2018 · 42 citations
5GBD-2010 overestimates deaths from road injuries in OECD countries: new methods perform poorlyOriginal Research · 2015 · 36 citations

More related papers

Child Mortality Estimation: A Comparison of UN IGME and IHME Estimates of Levels and Trends in Under-Five Mortality Rates and Deaths2012
The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 20172020
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 20162018

More from Liver International

The aMAP Score Effectively Stratifies Hepatocellular Carcinoma Risk in the Steatotic Liver Disease PopulationWed,
Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With CirrhosisWed,